IPO
VC-backed Circassia valued at £581m for IPO
Largest LSE IPO of VC- or PE-backed UK healthcare company in decade
VC-backed King prices IPO, valued at $7.5bn
Company to net up to $612.72m from offering
IPO to value ISS at nearly €4bn
One million shares placed by EQT and Goldman Sachs
Warburg to reap 4.5x in Poundland IPO
Warburg Pincus is set to reap a 4.5x money multiple and an IRR of more than 50% in the flotation of portfolio company Poundland, which has been valued at ТЃ750m after setting its price range for its admission to the London Stock Exchange.
Mid-market players fear UK IPO disaster
Is the market approaching a bust?
VC-backed McPhy to float on Euronext
Company could raise up to €24.2m
Altor-backed OW Bunker plans flotation
Altor finds exit after seven-year holding
TPG reaps $479m in Lenta IPO
Russian hypermarket chain Lenta raised $952m in its IPO on the London Stock Exchange on Friday, with a market cap of $4.3bn and an enterprise value of $5.4bn.
VC-backed Horizon Discovery plans £25m IPO
Horizon Discovery Group, a Cambridge-based biotech backed by DFJ Esprit and Roche Venture Fund among others, is planning to raise ТЃ25m in its IPO on the AIM segment of the London Stock Exchange.
KKR's Pets At Home IPO to value company at £1bn
KKR-backed Pets At Home has set the price range for its IPO on the London Stock Exchange, valuing the company at more than ТЃ1bn.
Arle floats DX Group
Arle Capital Partners-backed DX Group has priced its IPO on AIM and will start trading this week.
Upcoming IPO to value Warburg-backed Poundland at £750m
UK discount retailer Poundland, backed by Warburg Pincus, has announced its intention to list on the London Stock Exchange.
VC-backed King files for $500m IPO
King Digital Entertainment, the venture-backed UK games developer behind Candy Crush Saga, has filed with the US Securities and Exchange Commission (SEC) for a $500m IPO on the NYSE.
TPG's Lenta to raise up to $1bn in IPO
Russian hypermarket chain Lenta, backed by TPG Capital and VTB Capital Private Equity, plans on raising up to $1bn in its IPO on the London Stock Exchange and Moscow Exchange.
Hellman & Friedman's GTT launches IPO
Hellman & Friedman-backed Gaz Transport & Technigaz (GTT), a French marine technology and engineering company, plans on raising up to €675m in an IPO on the Euronext Paris.
Deal in focus: uniQure raises $91.8m in IPO
Netherlands-based uniQure’s debut on the Nasdaq marks one of the latest in a string of European venture capital-backed biotechs flocking to the US markets, but the lack of activity in Europe's public markets does not necessarily equate to a slowdown in...
Stable markets and high liquidity to boost Nordic exits
The Nordic region saw disappointing dealflow in 2013, despite an open and liquid financing market - but the industry is upbeat on exit prospects for 2014. Karin Wasteson reports
Frog Capital backs RatedPeople.com pre-IPO round
Frog Capital and Western Technology Investment (WTI) have injected ТЃ6.5m into its portfolio company RatedPeople.com in a pre-IPO investment round.
VC-backed Egalet raises $50.4m in IPO
VC-backed UK pharma Egalet has raised $50.4m in its IPO on the Nasdaq, giving the company a market cap of $166.8m.
VC-backed Circassia to float on LSE
Circassia, a UK allergy treatment developer backed by several investors, has announced its plans to float on the London Stock Exchange (LSE) next month.
VC-backed uniQure raises $91.8m in IPO
Venture capital-backed Dutch gene therapy company uniQure raised well above its original expectation in its listing on the Nasdaq, bagging $91.8m.
HgCapital to reap 2.1x in Manx IPO
The IPO of HgCapital's Isle of Man-based telecoms operator Manx Telecom will give the company a market cap of around ТЃ160.2m and generate a 2.1x money multiple for its backer.
VC-backed Crossject to list on NYSE Alternext
French medical device company Crossject, backed by a consortium of local venture capital firms, is hoping to raise up to €12.9m in its IPO on the NYSE Alternext Paris.
Fundraises to flotations: a promising year for the UK
The UK market witnessed swathes of fund closes and a surprising number of IPOs last year. But will this positive trend continue in 2014? Alice Murray reports